Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Swift Medical Receives FDA 510(k) Clearance for Swift Ray™ Spectral Imaging Device

8 August 2026 · By · Wire by Fusion42

Published

8 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at courierpress.com →

◆ Verified

Fusion42 · 28 August 2026 · Fusion42 review

Swift Medical has received FDA 510(k) clearance for its Swift Ray™ spectral imaging device, a portable fluorescence imaging tool integrated with their AI-powered wound assessment platform designed to improve real-time wound care.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

FDA clearance for Swift Ray™ opens point-of-care imaging to handheld devices, letting you offer clinics and home health a more portable wound assessment tool that integrates with AI analytics. This approval creates new pathways to embed your software in clinical workflows backed by hardware, expanding recurring revenue and reimbursement opportunities.

◆ Coverage

1 source · 8 Aug 2026

◆ Related on Wire

◆ Topics

Medtechfda-clearancemedical-devicewound-carespectral-imagingai-medical